Masanori Oshi

33PUBLICATIONS
30CO-AUTHORS
Communications engineering not elsewhere classifiedCancer diagnosisPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Women's studies (incl. girls' studies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Aug 13, 2026
Correction: Tokumaru et al. High Expression of microRNA-143 Is Associated with Favorable Tumor Immune Microenvironment and Better Survival in Estrogen Receptor Positive Breast Cancer. Int. J. Mol. Sci. 2020, 21, 3213.

|Jul 31, 2026
Molecular dichotomy of mucinous carcinoma defined by the presence of solid papillary carcinoma components: an integrative transcriptomic analysis.

|Jun 25, 2026
A Multiresolution Breast Cancer CIBERSORTx Resource Validated for Accuracy, Interpretive Limits, and Biological and Clinical Coherence in Tumor Microenvironment Deconvolution.

|Dec 04, 2025
Multidimensional impact of fixed-dose subcutaneous trastuzumab-pertuzumab on oncology workflow and patient time burden in a real-world study.

Masanori Oshi, Tomo Nakayama, Ichiro Ota

|Jul 25, 2025
Unique Biological Characteristics of Patients with High Gleason Score and Localized/Locally Advanced Prostate Cancer Using an In Silico Translational Approach.

Shiori Miyachi, Masanori Oshi, Takeshi Sasaki

|Mar 27, 2024
Enhanced epithelial-mesenchymal transition signatures are linked with adverse tumor microenvironment, angiogenesis and worse survival in gastric cancer.

Masanori Oshi, Arya Mariam Roy, Li Yan

Pageof 6

Frequent Collaborators

29 joint publications

Kazuaki Takabe

20 joint publications

Yoshihisa Tokumaru

4 joint publications

Eriko Katsuta

3 joint publications

Maiko Okano